82
ECP 2014 ·
London
Poster Presentations
a
Sunday
Sunday, 31 Aug
PS-03
079
Breast angiosarcoma: Evidence of lym-
phatic origin and MYC amplification in
post-radiotherapy breast angiosarcomas
M. Teresa Soler Monsó,
Spain
H. A. Florez, A. Petit, F. Climent,
A. Valdivielso, M. A. Eraso, A. López Ojeda,
V. Peg, E. Condom
080
Molecular subtyping of breast invasive
ductal carcinomain women older than 75
years
Ilhem Bettaieb,
Tunisia
S. Abdeljaoued, A. Goucha, H. Bouzaiene,
S. Miladi, W. Jomaa, T. Ben Dhieb, K. Rahal,
A. El-May, A. Gamoudi, A. Zehani-Kassar
081
International ring trial for evaluation of
breast cancer morphology in PAXgene
fixed tissue compared to formalin fixed
samples
Christian Viertler,
Austria
P. Verderio, C. M. Ciniselli, S. Pizzamiglio,
S. Gündisch, M. Kap, P. Riegman, K.-F.
Becker, K. Zatloukal, P. Regitnig
082
Peroxisome proliferator-activated recep-
tor gamma expression is useful predic-
tive and prognostic tool in luminal breast
cancer
Rezvan Abduljabbar,
United Kingdom
D. Jerjees, A. Green, C. Nolan, L. Buluwela,
S. Ali, E. Rakha, I. Ellis
083
Frequency of MYB rearrangement in ade-
noid cystic carcinoma of the breast as
detected by fluorescent in situ hybridiza-
tion
Rafael Jimenez,
USA
W. Sukov, T. Despins, C. Reynolds, J. Garcia
084
Accuracy of estrogen and progesterone
receptor immunohistochemical testing in
breast cancer: Canadian Immunohisto-
chemistry Quality Control (CIQC) program
Martin Hyrcza,
Canada
N. Makretsov, S. Mallett, J. Garratt,
E. Torlakovic, C. B. Gilks
085
Impact of the new ASCO/CAP recommen-
dations for the determination of HER2 by
immunohistochemistry (IHC)
Jessica Camacho,
Spain
J. Temprana Salvador, S. Díaz,
S. Ramon y Cajal, V. Peg
086
The enhanced role of biomedical scientists
in the histological dissection of axillary
lymph node clearance specimens
James Sampson,
United Kingdom
Y. Bury
087
Audit of end-to-end turnaround times for
mastectomy specimens in a District Gen-
eral Hospital, using locally agreed stand-
ards and targets from the key performance
indicators recommended by the Royal Col-
lege of Pathologists
Katharine Sheppard,
United Kingdom
L. Kankate
088
ERK1/2 expression in breast cancer: The
impact of subcellular localisation
Dena Jerjees,
United Kingdom
O. Nejm, S. Mirza, R. Abduljabbar,
N. Alsubhi, C. Nolan, A. Green, P. Tighe,
V. Band, I. Ellis, E. Rakha
089
Deciphering the role of PTEN and its role
in the DNA damage response in breast
cancer
Nouf Alsubhi,
United Kingdom
W. Flesher, A. Alshareeda, A. Muftah,
D. Jerjees, R. Abduljabbar, M. Al-Kaabi,
A. Green, S. Madhusudan, I. Ellis, E. Rakha
090
Pro and anti-apoptotic profiles in molecu-
lar subtypes of breast carcinoma
Irina-Draga Caruntu,
Romania
C. Popescu, L. Lozneanu, R. E. Avadanei,
S.-E. Giusca, C. Amalinei, R. Balan
091
Mammary myofibroblastoma: Case report
Malgorzata Kolos,
Poland
A. Wasaznik-Jedras, A. Nasierowska-Guttmejer
